Pycnogenol supplementation reduces pain and stiffness and improves physical function in adults with knee osteoarthritis

Reza Farid, Zahra Mirfeizi, Mahyar Mirheidari, Zahra Rezaieyazdi, Hassan Mansouri, Habib Esmaelli, Sherma Zibadi, Peter Rohdewald, Ronald R Watson

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Knee osteoarthritis (OA) is a common degenerative joint disorder and a major cause of pain and disability. The purpose of this study was to investigate the potential effect of Pycnogenol (Horphag Research, Ltd, Geneva, Switzerland), a flavonoid-rich dietary supplement, on the symptoms of knee OA. Thirty-seven osteoarthritic patients were enrolled in a randomized, double-blind, placebo-controlled trial with parallel-group design. Patients received either placebo or Pycnogenol pills (50 mg, three times daily) in a blinded fashion for 3 months. Osteoarthritis clinical symptoms were evaluated monthly with Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index. Nonsteroidal anti-inflammatory drugs (NSAIDs) or selective cyclooxygenase 2 (COX-2) inhibitors usage was also assessed. In the Pycnogenol group, there was a significant improvement in total WOMAC score and WOMAC subscale score of pain and physical function at 60 and 90 days of treatment. At 90 days, significant reduction of 43%, 35%, 52%, and 49% in self-reported pain, stiffness, physical function, and composite WOMAC score, respectively, were reported in Pycnogenol group, whereas the placebo group showed no significant changes. The dosage and frequency of NSAIDs or COX-2 inhibitors usage were increased in placebo group, which were significantly less in Pycnogenol group. The results of this study indicate the efficacy of Pycnogenol in alleviating osteoarthritis symptoms and reducing the need for NSAIDs or COX-2 inhibitors administration. This beneficial effect of Pycnogenol might be due to its antioxidant and anti-inflammatory properties. Further research is warranted to determine the underlying mechanism associated with this apparent effect.

Original languageEnglish (US)
Pages (from-to)692-697
Number of pages6
JournalNutrition Research
Volume27
Issue number11
DOIs
StatePublished - Nov 2007

Fingerprint

Knee Osteoarthritis
Pain
Cyclooxygenase 2 Inhibitors
Anti-Inflammatory Agents
Placebos
Osteoarthritis
Pharmaceutical Preparations
Ontario
Dietary Supplements
pycnogenols
Switzerland
Research
Flavonoids
Antioxidants
Joints

Keywords

  • Antioxidant
  • Flavonoid
  • Knee
  • Osteoarthritis
  • Pycnogenol

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Pycnogenol supplementation reduces pain and stiffness and improves physical function in adults with knee osteoarthritis. / Farid, Reza; Mirfeizi, Zahra; Mirheidari, Mahyar; Rezaieyazdi, Zahra; Mansouri, Hassan; Esmaelli, Habib; Zibadi, Sherma; Rohdewald, Peter; Watson, Ronald R.

In: Nutrition Research, Vol. 27, No. 11, 11.2007, p. 692-697.

Research output: Contribution to journalArticle

Farid, R, Mirfeizi, Z, Mirheidari, M, Rezaieyazdi, Z, Mansouri, H, Esmaelli, H, Zibadi, S, Rohdewald, P & Watson, RR 2007, 'Pycnogenol supplementation reduces pain and stiffness and improves physical function in adults with knee osteoarthritis', Nutrition Research, vol. 27, no. 11, pp. 692-697. https://doi.org/10.1016/j.nutres.2007.09.007
Farid, Reza ; Mirfeizi, Zahra ; Mirheidari, Mahyar ; Rezaieyazdi, Zahra ; Mansouri, Hassan ; Esmaelli, Habib ; Zibadi, Sherma ; Rohdewald, Peter ; Watson, Ronald R. / Pycnogenol supplementation reduces pain and stiffness and improves physical function in adults with knee osteoarthritis. In: Nutrition Research. 2007 ; Vol. 27, No. 11. pp. 692-697.
@article{fcfffdec37d040e3924fbd431fbe8ee8,
title = "Pycnogenol supplementation reduces pain and stiffness and improves physical function in adults with knee osteoarthritis",
abstract = "Knee osteoarthritis (OA) is a common degenerative joint disorder and a major cause of pain and disability. The purpose of this study was to investigate the potential effect of Pycnogenol (Horphag Research, Ltd, Geneva, Switzerland), a flavonoid-rich dietary supplement, on the symptoms of knee OA. Thirty-seven osteoarthritic patients were enrolled in a randomized, double-blind, placebo-controlled trial with parallel-group design. Patients received either placebo or Pycnogenol pills (50 mg, three times daily) in a blinded fashion for 3 months. Osteoarthritis clinical symptoms were evaluated monthly with Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index. Nonsteroidal anti-inflammatory drugs (NSAIDs) or selective cyclooxygenase 2 (COX-2) inhibitors usage was also assessed. In the Pycnogenol group, there was a significant improvement in total WOMAC score and WOMAC subscale score of pain and physical function at 60 and 90 days of treatment. At 90 days, significant reduction of 43{\%}, 35{\%}, 52{\%}, and 49{\%} in self-reported pain, stiffness, physical function, and composite WOMAC score, respectively, were reported in Pycnogenol group, whereas the placebo group showed no significant changes. The dosage and frequency of NSAIDs or COX-2 inhibitors usage were increased in placebo group, which were significantly less in Pycnogenol group. The results of this study indicate the efficacy of Pycnogenol in alleviating osteoarthritis symptoms and reducing the need for NSAIDs or COX-2 inhibitors administration. This beneficial effect of Pycnogenol might be due to its antioxidant and anti-inflammatory properties. Further research is warranted to determine the underlying mechanism associated with this apparent effect.",
keywords = "Antioxidant, Flavonoid, Knee, Osteoarthritis, Pycnogenol",
author = "Reza Farid and Zahra Mirfeizi and Mahyar Mirheidari and Zahra Rezaieyazdi and Hassan Mansouri and Habib Esmaelli and Sherma Zibadi and Peter Rohdewald and Watson, {Ronald R}",
year = "2007",
month = "11",
doi = "10.1016/j.nutres.2007.09.007",
language = "English (US)",
volume = "27",
pages = "692--697",
journal = "Nutrition Research",
issn = "0271-5317",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Pycnogenol supplementation reduces pain and stiffness and improves physical function in adults with knee osteoarthritis

AU - Farid, Reza

AU - Mirfeizi, Zahra

AU - Mirheidari, Mahyar

AU - Rezaieyazdi, Zahra

AU - Mansouri, Hassan

AU - Esmaelli, Habib

AU - Zibadi, Sherma

AU - Rohdewald, Peter

AU - Watson, Ronald R

PY - 2007/11

Y1 - 2007/11

N2 - Knee osteoarthritis (OA) is a common degenerative joint disorder and a major cause of pain and disability. The purpose of this study was to investigate the potential effect of Pycnogenol (Horphag Research, Ltd, Geneva, Switzerland), a flavonoid-rich dietary supplement, on the symptoms of knee OA. Thirty-seven osteoarthritic patients were enrolled in a randomized, double-blind, placebo-controlled trial with parallel-group design. Patients received either placebo or Pycnogenol pills (50 mg, three times daily) in a blinded fashion for 3 months. Osteoarthritis clinical symptoms were evaluated monthly with Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index. Nonsteroidal anti-inflammatory drugs (NSAIDs) or selective cyclooxygenase 2 (COX-2) inhibitors usage was also assessed. In the Pycnogenol group, there was a significant improvement in total WOMAC score and WOMAC subscale score of pain and physical function at 60 and 90 days of treatment. At 90 days, significant reduction of 43%, 35%, 52%, and 49% in self-reported pain, stiffness, physical function, and composite WOMAC score, respectively, were reported in Pycnogenol group, whereas the placebo group showed no significant changes. The dosage and frequency of NSAIDs or COX-2 inhibitors usage were increased in placebo group, which were significantly less in Pycnogenol group. The results of this study indicate the efficacy of Pycnogenol in alleviating osteoarthritis symptoms and reducing the need for NSAIDs or COX-2 inhibitors administration. This beneficial effect of Pycnogenol might be due to its antioxidant and anti-inflammatory properties. Further research is warranted to determine the underlying mechanism associated with this apparent effect.

AB - Knee osteoarthritis (OA) is a common degenerative joint disorder and a major cause of pain and disability. The purpose of this study was to investigate the potential effect of Pycnogenol (Horphag Research, Ltd, Geneva, Switzerland), a flavonoid-rich dietary supplement, on the symptoms of knee OA. Thirty-seven osteoarthritic patients were enrolled in a randomized, double-blind, placebo-controlled trial with parallel-group design. Patients received either placebo or Pycnogenol pills (50 mg, three times daily) in a blinded fashion for 3 months. Osteoarthritis clinical symptoms were evaluated monthly with Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index. Nonsteroidal anti-inflammatory drugs (NSAIDs) or selective cyclooxygenase 2 (COX-2) inhibitors usage was also assessed. In the Pycnogenol group, there was a significant improvement in total WOMAC score and WOMAC subscale score of pain and physical function at 60 and 90 days of treatment. At 90 days, significant reduction of 43%, 35%, 52%, and 49% in self-reported pain, stiffness, physical function, and composite WOMAC score, respectively, were reported in Pycnogenol group, whereas the placebo group showed no significant changes. The dosage and frequency of NSAIDs or COX-2 inhibitors usage were increased in placebo group, which were significantly less in Pycnogenol group. The results of this study indicate the efficacy of Pycnogenol in alleviating osteoarthritis symptoms and reducing the need for NSAIDs or COX-2 inhibitors administration. This beneficial effect of Pycnogenol might be due to its antioxidant and anti-inflammatory properties. Further research is warranted to determine the underlying mechanism associated with this apparent effect.

KW - Antioxidant

KW - Flavonoid

KW - Knee

KW - Osteoarthritis

KW - Pycnogenol

UR - http://www.scopus.com/inward/record.url?scp=36148962423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36148962423&partnerID=8YFLogxK

U2 - 10.1016/j.nutres.2007.09.007

DO - 10.1016/j.nutres.2007.09.007

M3 - Article

AN - SCOPUS:36148962423

VL - 27

SP - 692

EP - 697

JO - Nutrition Research

JF - Nutrition Research

SN - 0271-5317

IS - 11

ER -